ORI Updates

The Office of Research Integrity (ORI) within the Office of the Assistant Secretary for Health (OASH), Department of Health and Human Services (DHHS), is seeking highly qualified candidates for two positions: a Scientist-Investigator position within the Division of Investigative Oversight (DIO) and an Education and Integrity Specialist position within the Division of Education and Integrity (DEI). The positions are full-time and are located at the Rockville, MD office. Candidates interested in applying for both positions should include “Investigator/Specialist” in the subject line of their email and address this in their expression of interest.

ORI Announces a Request for Information (RFI) on the 2005 Public Health Service Policies on Research Misconduct. 

ORI found that Ritankar Majumdar, Ph.D., who was a postdoctoral fellow in the intramural program of the Laboratory of Cellular and Molecular Biology (CMB), Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically the NCI Intramural Research Program.

ORI released forecasts for two funding opportunity announcements (FOAs) for research integrity grants: Ensuring Research Integrity - Research, Development, and Demonstration; and Ensuring Research Integrity - Conferences.

ORI found that Stuart G. Jarrett, Ph.D. (Respondent), former research-track assistant professor, Department of Toxicology and Cancer Biology and Markey Cancer Center, University of Kentucky (UK) College of Medicine, engaged in research misconduct under 42 C.F.R. Part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), NIH, and National Institute of Environmental Health Sciences (NIEHS), NIH.

ORI found that Janina Jiang, M.D., Ph.D., former Assistant Researcher in the Department of Pathology & Laboratory Medicine at the David Geffen School of Medicine, University of California, Los Angeles (UCLA) engaged in research misconduct in research included in grant applications submitted for U.S. Public Health Service (PHS) funds, specifically the National Cancer Institute (NCI), National Institutes of Health (NIH), the National Center for Advancing Translational Sciences (NCATS), NIH, and the National Institute of Allergy and Infectious Diseases (NIAID), NIH.

ORI awarded three Ensuring Research Integrity- Research, Development, and Demonstration grants.

The Office of Research Integrity (ORI) is recruiting for a Senior Executive Service position to serve as the Director.

ORI found that Dr. Toni M. Brand, who was a graduate student in the Department of Human Oncology, UWM, and subsequently a research fellow in the Department of Otolaryngology - Head and Neck Surgery, UCSF, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), National Center for Research Resources (NCRR), NIH, National Center for Translational Sciences (NCATS), NIH, National Institute of General Medical Sciences (NIGMS), NIH, and National Institute of Dental and Craniofacial Research (NIDCR), NIH.

ORI has released its FY 2021 Annual Report, which highlights activities over the past year related to investigative oversight, communications, ORI’s grant program, ORI intramural projects, and ORI’s compliance programs.